CB Insights
Technology Market Intelligence
Technology Market Intelligence
Intercell AG, (formerly Iomai Corp.) has developed a method to safely and more effectively deliver vaccines through the use of a skin patch and without any injections.
Company (Acquired)
Phone:
Campus Vienna Biocenter 6
Austria
| Total Funding | Date of Last Funding | |
|---|---|---|
| Intercell | $0M | May 29, 2013 |
| Aura Biosciences | $86.8M | Dec 21, 2017 |
| Agentase | $0.1M | Apr 9, 2004 |
| See all 15 competitors | ||
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Name | Firm |
|---|---|
| Login to see details | Phase4 Ventures |
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Isolated polypeptide of the toxin a and toxin b proteins of | Sep 05, 2011 | Mar 21, 2017 | Patent |
| Mutant fragments of ospa and methods and uses relating thereto | Mar 14, 2013 | Mar 24, 2015 | Patent |
| Untitled | May 06, 2013 | Feb 10, 2015 | Patent |
| Enterococcus antigens | Mar 28, 2011 | Sep 10, 2013 | Patent |
| Small | Jul 06, 2007 | Sep 10, 2013 | Patent |
Download PDF